MwanzoDXCM • NASDAQ
add
DexCom Inc
Bei iliyotangulia
$ 65.12
Bei za siku
$ 64.93 - $ 66.37
Bei za mwaka
$ 57.52 - $ 93.24
Thamani ya kampuni katika soko
25.57B USD
Wastani wa hisa zilizouzwa
5.86M
Uwiano wa bei na mapato
46.56
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.16B | 15.21% |
Matumizi ya uendeshaji wa biashara | 476.20M | 1.60% |
Mapato halisi | 179.80M | 25.30% |
Kiwango cha faida halisi | 15.54 | 8.75% |
Mapato kwa kila hisa | 0.48 | 11.63% |
EBITDA | 275.60M | 31.18% |
Asilimia ya kodi ya mapato | 25.43% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.93B | -6.13% |
Jumla ya mali | 7.33B | 7.76% |
Jumla ya dhima | 4.75B | 8.91% |
Jumla ya hisa | 2.57B | — |
hisa zilizosalia | 392.16M | — |
Uwiano wa bei na thamani | 9.93 | — |
Faida inayotokana na mali | 7.55% | — |
Faida inayotokana mtaji | 10.63% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 179.80M | 25.30% |
Pesa kutokana na shughuli | 303.00M | 8.45% |
Pesa kutokana na uwekezaji | -63.60M | 66.33% |
Pesa kutokana na ufadhili | -1.70M | -21.43% |
Mabadiliko halisi ya pesa taslimu | 254.20M | 188.54% |
Mtiririko huru wa pesa | 165.64M | -33.63% |
Kuhusu
Dexcom, Inc. is an American healthcare company that develops, manufactures, produces, and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1999
Makao Makuu
Tovuti
Wafanyakazi
10,250
